Nyxoid (Naloxone)

Naloxone, the active ingredient in Nyxoid, is an opioid antagonist presented as a nasal spray for nasal use. It rapidly reverses the effects of opioid overdose in both adults and pediatric patients, restoring normal breathing and consciousness when administered promptly.

GNH USA supplies Nyxoid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for cross‑border distribution, ensuring reliable access to this critical emergency medication globally.

Naloxone, an opioid antagonist, is used to counteract opioid toxicity and overdose.

Opioid overdose: rapid reversal of life‑threatening respiratory depression. Opioid toxicity: restores normal respiration and consciousness in patients exposed to excess opioids. Opioid‑induced respiratory depression: counteracts sedation and hypoventilation caused by opioid agonists.

Naloxone is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nasal irritation or burning sensation at the site of administration. - Rhinorrhea or watery nasal discharge. - Sneezing or mild nasal congestion. - Headache or dizziness. - Nausea or mild gastrointestinal upset.

Serious or Rare Side Effects: - Hypertension or marked increase in blood pressure. - Tachycardia or irregular heart rhythm. - Seizures, especially in patients with pre‑existing seizure disorders. - Severe allergic reactions, including anaphylaxis. - Pulmonary edema or acute respiratory distress.

Naloxone should be used with careful clinical assessment and monitoring. - Assess patient: confirm opioid overdose before administration. - Monitor vital signs: observe respiratory rate, oxygen saturation, and consciousness after dosing. - Re‑dose if needed: be prepared for repeat administration with long‑acting opioids. - Caution in pregnancy: limited data; weigh benefits against potential risks. - Avoid use in patients with known hypersensitivity to naloxone. - Store at room temperature: keep in original packaging, protect from moisture and light.

Naloxone may interact with other agents that affect opioid pathways.

Major Interactions (Avoid): - Concurrent use of other opioid antagonists (e.g., naltrexone) may precipitate severe withdrawal. - Administration with potent opioid agonists (e.g., fentanyl) without appropriate monitoring can reduce reversal effectiveness.

Moderate Interactions (Monitor Closely): - Use with monoamine oxidase inhibitors may increase risk of hypertensive episodes. - Co‑administration with sedatives or CNS depressants may mask residual opioid effects. - Interaction with drugs that alter nasal mucosa (e.g., decongestants) may affect absorption.